BioCryst Pharma (BCRX) Reports Event of Default with PhaRMA Notes
Tweet Send to a Friend
The RAPIACTA royalty stream from Shionogi & Co. (“Shionogi”), the partner of BioCryst Pharma (Nasdaq: BCRX) in Japan, was insufficient ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE